NCT01897324View on ClinicalTrials.gov

IVF/ICSI Protocols in Poor Responders With Growth Hormone

PHASE4CompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Female Infertility Due to Diminished Ovarian Reserve
Interventions
DRUG

Growth hormone (Norditropin, Novo nordisk)

Trial Locations (1)

12311

private IVF medical center, Giza

All Listed Sponsors
lead

Woman's Health University Hospital, Egypt

OTHER

NCT01897324 - IVF/ICSI Protocols in Poor Responders With Growth Hormone | Biotech Hunter | Biotech Hunter